Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers
Abstract Partial and/or heterogeneous irradiation of established (i.e., large, vascularized) tumors by α‐particles that exhibit only a 4-5 cell‐diameter range in tissue, limits the therapeutic effect, since regions not being hit by the high energy α‐particles are likely not to be killed. This study...
Saved in:
Main Authors: | Dominick Salerno (Author), Alaina Howe (Author), Omkar Bhatavdekar (Author), Anders Josefsson (Author), Jesus Pacheco‐Torres (Author), Zaver M. Bhujwalla (Author), Kathleen L. Gabrielson (Author), Stavroula Sofou (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
by: Dominick Salerno, et al.
Published: (2021) -
The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia
by: Omkar Bhatavdekar, et al.
Published: (2022) -
Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015) -
Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015) -
Correlation between Prostate Specific Antigen and Prostate Biopsy Gleason Score
by: Ngwu PE, et al.
Published: (2019)